Buspirone for the treatment of dementia with behavioral disturbance

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Psychogeriatrics

• Publication date

  2017-01-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S1041610216002441PMID 28124634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mood stabilizers

  2019cited by this paper
• Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.

  2015cited by this paper
• Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

  2014cited by this paper
• Guidelines for the Management of Cognitive and Behavioral Problems in Dementia

  2012cited by this paper
• Health insurance-motivated disability enrollment and the ACA.

  2012cited by this paper
• Behavioral Disturbance in Dementia

  2012cited by this paper
• Relapse risk after discontinuation of risperidone in Alzheimer's disease.

  2012cited by this paper
• Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: An update review

  2012cited by this paper
• Antidepressants for agitation and psychosis in dementia.

  2011cited by this paper
• Agitated behavior in persons with dementia: the relationship between type of behavior, its frequency, and its disruptiveness.

  2008cited by this paper
• Buspirone for anxiety and agitation in dementia.

  2003cited by this paper
• Agitation in Demented Patients in an Acute Care Hospital: Prevalence, Disruptiveness, and Staff Burden

  2001cited by this paper
• Treatment of agitation in dementia.

  1997cited by this paper
• Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease.

  1996cited by this paper
• Nonneuroleptic Treatment of Disruptive Behavior in Organic Mental Syndromes

  1992cited by this paper
• A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia

  1990cited by this paper
• Buspirone in treatment of agitated demented patient.

  1988cited by this paper
• Guidelines for management

  1972cited by this paper

• Brexpiprazole for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease: Clinical Perspectives

  2025cites this paper
• Disparity of Prescribed Psychotropics in Alzheimer’s Disease with Neuropsychiatric Symptoms

  2025cites this paper
• Sex Differences in Risk Factors among Alzheimer's Dementia Patients with Metabolic Encephalopathy

  2025cites this paper
• Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless Condition

  2025cites this paper
• Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet.

  2025cites this paper
• Review of Current Clinical Options for the Management of Behavioral and Psychological Symptoms of Dementia.

  2024cites this paper
• Inhibition of Axitinib on Buspirone Metabolism in vitro and in vivo

  2022cites this paper
• Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer’s Disease

  2022cites this paper
• Management of Psychiatric Symptoms in Dementia.

  2022cites this paper
• Cognitive Impairment Evaluation and Management

  2020cites this paper
• Mapping and Imaging the Aggressive Brain in Animals and Humans

  2020cites this paper
• Informal Caregivers’ Roles in Dementia: The Impact on Their Quality of Life

  2020cites this paper
• Divergent pathways mediate 5-HT1A receptor agonist effects on close social interaction, grooming and aggressive behaviour in mice: Exploring the involvement of the oxytocin and vasopressin systems

  2020cites this paper
• The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions

  2019cites this paper
• Pharmacologic Management of Agitation in Patients with Dementia

  2019cites this paper
• Optimizing Care for Older Adults With Dementia-Associated Psychosis

  2018cites this paper